Back
Context Therapeutics 10K Form
Sell
10
CNTX
Context Therapeutics
Last Price:
1.39
Seasonality Move:
-30%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNTX News And Ratings
See the #1 stock for the next 7 days that we like better than CNTX
CNTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-16.69M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.12 |
| Price / Book: | 1.24 |
Profitability
| EPS (TTM): | -0.91000 |
|---|---|
| Net Income (TTM): | $-30.15M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Context Therapeutics Earnings Forecast
Key Context Therapeutics Financial Ratios
- The Interest Expense is -0.61% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Context Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CNTX |
| Website: | contexttherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CNTX Technical Analysis vs Fundamental Analysis
Sell
10
Context Therapeutics (CNTX)
is a Sell
Is Context Therapeutics a Buy or a Sell?
-
Context Therapeutics stock is rated a Sell
The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.